drugset / Trial / NCT06137040

Timely Administration of IV Magnesium Sulfate in Patients With a Moderate Asthma Exacerbation

NCT06137040

Phase 0 Recruiting 100 enrolled University of Oklahoma
RandomizedParallel-groupDouble-blindTreatment

Summary

This study aims to identify whether early administration of magnesium sulfate in moderate asthma exacerbations can potentially avoid admission, decrease length of stay in the emergency department (ED), decrease length of stay (LOS) in the general hospital floor vs pediatric intensive care unit (PICU), and decrease the need for respiratory support.

Timeline

Start
2023-11-30
Primary completion
2025-05-31
Completion
2025-05-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Magnesium Sulfate Other / unclassified 750 mg Intravenous
Subject Magnesium Sulfate Other / unclassified 1000 mg Intravenous
Subject Magnesium Sulfate Other / unclassified 1500 mg Intravenous
Subject Magnesium Sulfate Other / unclassified 2000 mg Intravenous